NCT03897374 · ClinLogic LLC
Strategic Targeting for Optimal Prevention of Cancer
(STOP-Cancer)
What this study is about
The primary goal of the study is to record data over the observation period to evaluate the clinical benefit of using hereditary cancer genomic diagnostics to assess overall hereditary genetic cancer risk profile and to help guide physicians to pursue preventative measures, which may lead to early detection and treatment of the condition.
View original scientific description
The primary goal of the study is to record data over the observation period to evaluate the clinical benefit of using hereditary cancer genomic diagnostics to assess overall hereditary genetic cancer risk profile and to help guide physicians to pursue preventative measures, which may lead to early detection and treatment of the condition.
Interventions
DIAGNOSTIC_TEST
Genetic Testing
Buccal swab
Primary outcome measures
Genomic cancer screen
Time frame: 120 Days
A study subject is known to have personal and/or family history of cancer known to be influenced by genetic variation.
Genomic cancer screen
Time frame: 120 Days
A genotype known to be a predisposition for cancer.
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- Study subjects may be included in the Clinical Trial if they meet all of the following inclusion criteria:
- individuals, ages 65 years or older;
- must have met medical necessity for hereditary cancer genomic testing and allowed the physician to test based on medical necessity;
- hereditary cancer diagnostic test was ordered by a physician related to individual subject care considerations.
- study subject has or had cancer
- study subject has at least one family member with cirrent or past cancer
Exclusion criteria
- Study subjects will be excluded from the study if any of the following criteria apply: • study subject is currently hospitalized or incarcerated;
- study subject is unable to provide an accurate history due to mental incapacity
- study subject is currently abusing illicit and/or prescription drugs;
Where
- Prosper, Texas
Collaborators
MDGlobal
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Mar 19, 2026 · Source of record for eligibility and locations